This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
BNP can still be used for heart failure assessment, despite early increases during ARNI treatment.
Why it matters
Understanding BNP's role in heart failure is crucial for effective diagnosis and treatment. This study helps clarify how new therapies impact BNP levels.
How the study worked
The study reviews the mechanisms of BNP production and clearance, along with the effects of ARNI on BNP levels.
What this study cannot tell us
The study is primarily a review and does not present new experimental data.
Read the original research
B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Biology, 11(7)
Citation
Nishikimi, Toshio; Nakagawa, Yasuaki. (2022). B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?. Biology, 11(7). https://doi.org/10.3390/biology11071034